
Dotrawin MF 80mg/250mg Tablet
Marketer
Wellmark Lifesciences Private Limited
Salt Composition
Drotaverine (80mg) + Mefenamic Acid (250mg)
Overview Dotrawin MF 80mg/250mg Tablet
Abdominal pain relief is provided by the combined medication, Avelox MF 80mg/250mg Tablet. This medication alleviates abdominal pain, distension, discomfort, and spasms by relaxing the stomach and intestinal muscles. It also inhibits pain and discomfort-inducing neurotransmitters. Avelox MF 80mg/250mg Tablets should be taken with food, following your physician's prescribed dosage and duration. Dosage is tailored to your condition and response. Continue the medication as directed; premature discontinuation may cause symptom recurrence and condition worsening. Inform your healthcare provider of all other medications, as interactions are possible. Common side effects include diarrhea, nausea, vomiting, stomach ache, dry mouth, anorexia, thirst, and heartburn. Most are transient and self-limiting. Report any concerning side effects immediately. Dizziness and drowsiness may occur; avoid driving or mentally demanding tasks until the drug's effects are known. Alcohol should be avoided due to potential dizziness exacerbation. Inform your physician of pregnancy, pregnancy plans, or breastfeeding before using this medicine. Disclose any kidney or liver conditions for appropriate dosage adjustment.
Primary Ingredients of Dotrawin MF 80mg/250mg Tablet
The provided text is "undefined," which contains no information to rephrase. Therefore, no rewritten text can be provided.
Uses of Dotrawin MF 80mg/250mg Tablet
Managing abdominal discomfort
Major Benefits of Dotrawin MF 80mg/250mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Dotrawin MF 80mg/250mg Tablet should be administered with a meal.
Common Side effects of Dotrawin MF 80mg/250mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Dryness in mouth
- Heartburn
- Vertigo
- Insomnia (difficulty in sleeping)
- Hypotension (low blood pressure)
- Fast heart rate
- Sweating
- Constipation
- Increased liver enzymes
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Purpura
- Agranulocytosis (deficiency of granulocytes in the blood)
- Breathlessness
- Ringing in ear
- Abdominal pain
- Flatulence
- Indigestion
- Stomach inflammation
- Confusion
- Depression
How to use Dotrawin MF 80mg/250mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Dotrawin MF 80mg/250mg Tablet should be administered with a meal.
How Dotrawin MF 80mg/250mg Tablet works:
Combiflam MF, a formulation containing 80mg Drotaverine and 250mg Mefenamic Acid, provides relief from abdominal discomfort and cramping. Drotaverine, an antispasmodic agent, targets and alleviates abdominal smooth muscle spasms. Mefenamic Acid, a non-steroidal anti-inflammatory drug (NSAID), inhibits the production of inflammatory mediators responsible for pain and swelling in the abdomen.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Dotrawin MF 80mg/250mg Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Dotrawin MF 80mg/250mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
Data on the safety of Dotrawin MF 80mg/250mg Tablet while breastfeeding is lacking. Seek your physician's advice.
DrivingUNSAFE
Taking Dotrawin MF 80mg/250mg tablets might lead to adverse reactions that impair driving ability, as dizziness is a potential side effect.
KidneyCAUTION
Patients with kidney impairment should use Dotrawin MF 80mg/250mg Tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Dotrawin MF 80mg/250mg Tablets are contraindicated in individuals with severe kidney disease.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Dotrawin MF 80mg/250mg tablets. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Dotrawin MF 80mg/250mg Tablet :
Should you forget a Dotrawin MF 80mg/250mg Tablet dose, take it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Dotrawin MF 80mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
